PFC
MIRM icon

Phocas Financial Corp’s Mirum Pharmaceuticals MIRM Stock Holding History

Phocas Financial Corp’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.71M Buy
+14,637
New +$1.47M 0.24% 120
2025
Q3 		– Sell
-35,561
Closed -$1.81M – 154
2025
Q2 		$1.81M Buy
35,561
+5
+0% +$223 0.26% 105
2025
Q1 		$1.6M Sell
35,556
-2,029
-5% -$95.6K 0.25% 109
2024
Q4 		$1.55M Buy
+37,585
New +$1.57M 0.21% 118

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Phocas Financial Corp's MIRM Position: Q2 2026 in Review

Phocas Financial Corp opened a new position in Mirum Pharmaceuticals (MIRM) in Q2 2026: 14,637 shares worth $1.71M. The stake represents 0.24% of the portfolio and ranks #120 among its holdings. This is a return to the name: Phocas Financial Corp previously reported a position in MIRM as recently as Q2 2025.

Phocas Financial Corp first reported a position in MIRM in Q4 2024 and has held it in 4 quarters since. The position peaked at $1.81M in Q2 2025. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Phocas Financial Corp held 14,637 shares of Mirum Pharmaceuticals worth $1.71M as of Q2 2026.
  • Mirum Pharmaceuticals was a new Phocas Financial Corp position in Q2 2026.
  • Mirum Pharmaceuticals made up 0.24% of Phocas Financial Corp's portfolio in Q2 2026, its #120 holding.
  • Phocas Financial Corp first reported a position in Mirum Pharmaceuticals in Q4 2024 and has held it in 4 quarters since.
  • Phocas Financial Corp's Mirum Pharmaceuticals position peaked at $1.81M in Q2 2025.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Phocas Financial Corp's 13F filing for Q2 2026, filed 31 Jul 2026.